Li Kang Biomedical Co Stock

Li Kang Biomedical Co Liabilities

The The Liabilities of Li Kang Biomedical Co (6242.TWO) as of Aug 8, 2026 is 221.82 M TWD. In the previous year, The Liabilities was 179.93 M TWD — a change of 23.28% (higher).

Liabilities

221.82 MTWD

YoY

23.28%

Last updated:

In 2026, Li Kang Biomedical Co's total liabilities amounted to 221.82 M TWD, a 23.28% difference from the 179.93 M TWD total liabilities in the previous year.

Access this data via the Eulerpool API
Get Free API Key

Li Kang Biomedical Co Stock analysis

What does Li Kang Biomedical Co do? Li Kang Biomedical Co is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Li Kang Biomedical Co's Liabilities

Li Kang Biomedical Co's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Li Kang Biomedical Co's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Li Kang Biomedical Co's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Li Kang Biomedical Co's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Li Kang Biomedical Co’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Li Kang Biomedical Co stock

The Liabilities of Li Kang Biomedical Co is 221.82 M TWD in 2026.

The Liabilities of Li Kang Biomedical Co changed from 179.93 M TWD to 221.82 M TWD, representing a 23.28% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities Li Kang Biomedical Co since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's Li Kang Biomedical Co historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Li Kang Biomedical Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Li Kang Biomedical Co